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Abstract
Background: Changes in cellular phenotype result from underlying changes in mRNA transcription and translation. 
Endothelin-1 stimulates cardiomyocyte hypertrophy with associated changes in mRNA/protein expression and an 
increase in the rate of protein synthesis. Insulin also increases the rate of translation but does not promote overt 
cardiomyocyte hypertrophy. One mechanism of translational regulation is through 5' terminal oligopyrimidine tracts 
(TOPs) that, in response to growth stimuli, promote mRNA recruitment to polysomes for increased translation. TOP 
mRNAs include those encoding ribosomal proteins, but the full panoply remains to be established. Here, we used 
microarrays to compare the effects of endothelin-1 and insulin on the global transcriptome of neonatal rat 
cardiomyocytes, and on mRNA recruitment to polysomes (i.e. the translatome).
Results: Globally, endothelin-1 and insulin (1 h) promoted >1.5-fold significant (false discovery rate < 0.05) changes in 
expression of 341 and 38 RNAs, respectively. For these transcripts with this level of change there was little evidence of 
translational regulation. However, 1336 and 712 RNAs had >1.25-fold significant changes in expression in total and/or 
polysomal RNA induced by endothelin-1 or insulin, respectively, of which ~35% of endothelin-1-responsive and ~56% 
of insulin-responsive transcripts were translationally regulated. Of mRNAs for established proteins recruited to 
polysomes in response to insulin, 49 were known TOP mRNAs with a further 15 probable/possible TOP mRNAs, but 49 
had no identifiable TOP sequences or other consistent features in the 5' untranslated region.
Conclusions: Endothelin-1, rather than insulin, substantially affects global transcript expression to promote 
cardiomyocyte hypertrophy. Effects on RNA recruitment to polysomes are subtle, with differential effects of 
endothelin-1 and insulin on specific transcripts. Furthermore, although insulin promotes recruitment of TOP mRNAs to 
cardiomyocyte polysomes, not all recruited mRNAs are TOP mRNAs.
Background
Changes in the phenotype of cells (e.g. proliferation, dif-
ferentiation, hypertrophic growth) result from changes in
gene expression. Emphasis is often placed on RNA
expression, and the availability of microarray technology
has enabled studies of the global transcriptome. However,
gene expression is also influenced by the rate of transla-
tion into protein. The global rate of protein synthesis
relates to the capacity for and efficiency of translation
[1,2]. Capacity is increased by synthesis of ribosomal sub-
units and other translational components, whereas effi-
ciency is regulated by the rate of translational initiation
(assembly of initiation factors, "unwinding" of RNA sec-
ondary structures, scanning and recognition of the initia-
tion codon), and the rate of peptide chain elongation.
Individual mRNAs are subject to additional levels of
translational regulation, and elements in their 5' and 3'
untranslated regions (UTRs) may interact with regulatory
RNAs (e.g. antisense sequences, microRNAs) or RNA
binding proteins to modulate ribosomal association [2].
The 5' UTR particularly influences the rate of initiation
via 5' terminal oligopyrimidine tracts (TOPs), inclusion of
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short upstream open reading frames (uORFs), GC con-
tent and UTR length [2,3].
TOP mRNAs possess 5-15 pyrimidines at the 5' end,
usually starting with C [4]. They are subject to growth-
associated translational regulation, and stimulation with
serum increases their polysomal association. mRNAs
encoding ribosomal proteins, elongation factors and
some subunits of Eif3e initiation factor are all TOP
mRNAs [4,5]. Recruitment to polysomes increases their
rate of translation, thus increasing translational capacity.
Several studies have used microarrays to analyse RNA
recruitment to polysomes [6-10], and bioinformatics
approaches have been used to identify potential TOP
mRNAs [11]. However, the full panoply of TOP mRNAs
is not known and the extent to which translational regula-
tion is mediated through TOP mRNAs relative to other
mechanisms (e.g. uORFs) remains to be established.
Phosphoinositide 3' kinase (PI3K), signaling through pro-
tein kinase B (PKB, also known as Akt) and mammalian
target of rapamycin (mTOR), is particularly implicated in
translational regulation [1,12]. mTOR complex 1
(mTORC1) promotes phosphorylation (activation) of p70
S6 kinases (p70S6Ks) that phosphorylate the small ribo-
somal subunit protein S6 (Rps6), and this was proposed
to promote translation of TOP mRNAs. However, protein
synthesis and recruitment of TOP mRNAs to polysomes
in the presence of serum is not inhibited in p70S6K-null
cells [13], and alternative mechanisms and signaling path-
ways may operate. For example, p90 ribosomal S6 kinases
(p90RSKs), activated by extracellular signal-regulated
kinases 1/2 (ERK1/2), also phosphorylate Eif4b and Eef2k
[1]. Additionally, the pathways are integrated and ERK1/2
can activate mTORC1 independently of PI3K [1,12]. In a
global context, PI3K signaling also influences the global
rate of translation by promoting phosphorylation of 4E-
BP1 [1,12]. This promotes dissociation of 4E-BP1 from
Eif4e, allowing Eif4e to bind to the 7-methylGTP cap of
mRNAs and increase the rate of initiation.
Cardiomyocytes, the contractile cells of the heart, with-
draw from the cell cycle perinatally. Maturational growth
of the heart results from an increase in cell size, but cardi-
omyocytes also hypertrophy in response to physiological
stresses (e.g. hypertension) [14]. Cardiomyocyte hyper-
trophy is manifested in increased cell size and sarcomeric
content. This reflects underlying changes in gene/protein
expression, resulting from alterations in the transcrip-
tome coupled with an increase in the rate of protein syn-
thesis. Some would argue that the increased rate of
protein synthesis is a crucial factor in facilitating hyper-
trophy [15]. Various neurohumoral factors promote car-
diomyocyte hypertrophy including endothelin-1 (ET-1)
and other agonists that potently activate ERK1/2, and
ERK1/2 signaling is particularly implicated in promoting
hypertrophy [16]. Insulin is associated with cardiomyo-
cyte growth since it increases the rate of cardiac protein
synthesis [17] and, as in other cells, insulin potently acti-
vates PKB/Akt via PI3K in cardiomyocytes [18]. Insulin
activates ERK1/2 to a degree, but this is substantially less
than that induced by ET-1 and, although ET-1 activates
PKB/Akt to a minor degree, this is substantially less than
insulin [19]. Notably, insulin does not induce the same
hypertrophic phenotype as, for example, ET-1, and inhi-
bition of ERK1/2 signaling, but not PI3K, attenuates car-
diomyocyte hypertrophy induced by hypertrophic
agonists [19]. In hearts in vivo, pressure overload
increases recruitment of Rpl32 mRNA (an example of a
TOP mRNA) rather than non-TOP mRNAs (β-myosin
heavy chain) suggesting that the TOP mRNA mechanism
is an integral part of cardiac hypertrophy [20]. Similar
effects are seen in feline cardiomyocytes with ET-1 and
insulin, both of which activate m TOR. However , only a
single TOP mRNA was examined and whether this
extends to other established TOP mRNAs, or if there are
additional TOP mRNAs in the cardiac transcriptome is
unknown.
Previously, we reported the acute effects of ET-1 on the
cardiomyocyte transcriptome [21], identifying 1306
RNAs as temporally-regulated over the first 4 h of stimu-
lation. Most of the protein-coding RNAs are approxi-
mately equally changed in total and polysomal RNA
pools, suggesting that there is little translational regula-
tion of these transcripts. Here, we compare the changes
induced by ET-1 and insulin in the global cardiomyocyte
transcriptome and in transcript recruitment to poly-
somes. Unlike ET-1, insulin did not have a substantial
effect on global transcript expression, but both agonists
differentially affected RNA recruitment to polysomes.
Furthermore, whilst insulin did promote recruitment of
TOP RNAs to the polysomes, not all recruited mRNAs
possessed a TOP sequence.
Results
Signaling through to protein synthesis by ET-1 and insulin
To compare the effects of ET-1 and insulin on activation
of intracellular signaling pathways in cardiomyocytes,
extracts were immunoblotted with antibodies selective
for phosphorylated (activated) forms of ERK1/2, PKB/
Akt, mTOR, p70S6K and Rps6. Consistent with previous
studies [19], ET-1 (100 nM, 5 min) potently activated
ERK1/2 with little effect on PKB/Akt whereas insulin (50
mU/ml, 5 min) had little effect on ERK1/2 phosphoryla-
tion, but potently activated PKB/Akt (Figure 1A). Both
agonists promoted phosphorylation of mTOR(Ser2448),
p70S6K(Thr389) and Rps6(Ser235/Ser236) (Figure 1, B
and 1C). Although insulin consistently stimulated a
greater increase in phospho-mTOR(Ser2448) than ET-1,
this was not reflected in the degree of phosphorylation of
p70S6K(Thr389) and Rps6(Ser235/236). Our previousMarkou et al. BMC Genomics 2010, 11:343
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Figure 1 Protein kinase signaling and regulation of protein synthesis by ET-1 and insulin. Cardiomyocytes were exposed to 100 nM ET-1 or 50 
mU/ml insulin or left unstimulated. A-C, Cardiomyocytes were exposed to agonists for 5 min (A) or 15 min (B and C). Protein extracts were immuno-
blotted with antibodies to phosphorylated ERK1/2 (A, upper panel), phosphorylated PKB/Akt (A, lower panel), phosphorylated mTOR (B, top panel), 
phosphorylated p70S6k (B, upper center panel), phosphorylated Rps6 (B, lower center panel) or total mTOR (B, lower panel). Each set of samples was 
prepared from a separate preparation of cardiomyocytes. C, Bands from images in panel B were quantified by scanning densitometry. Results are 
means ± SEM (n = 3). * p < 0.05, # p < 0.01, † p < 0.001 relative to controls (one-way ANOVA with Tukey post-test). D, Cardiomyocytes were exposed 
to agonists for the total time indicated and rate of protein synthesis was measured over the last 1 h of incubation using [3H]-Phe. Results are means ± 
SEM (n = 5 independent preparations of cardiomyocytes). * p < 0.05, # p < 0.01, † p < 0.001 relative to controls, ‡ p < 0.05 relative to 2 h (one-way 
ANOVA with Tukey post-test). E, Cardiomyocytes were unstimulated (Control) or exposed to agonists/inhibitors as follows: ET-1 (5 min), PD184352 (2 
μM, 15 min), PD184352/ET-1 (10 min pretreatment with PD184352 before addition of ET-1 for 5 min), insulin (10 min), LY294002 (50 μM, 20 min), ra-
pamycin (1 μM, 20 min), LY294002/insulin or rapamycin/insulin (10 min pretreatment with inhibitor before addition of insulin for 10 min). Extracts 
were immunoblotted for phosphorylated and total ERK1/2, PKB/Akt and p70S6K as indicated. Experiments were repeated with similar results. F, Car-
diomyocytes were exposed for 2 h to 50 μM LY294005, 1 μM rapamycin, 2 μM PD184352, 100 nM ET-1 or 50 mU/ml insulin, or ET-1 or insulin in the 
presence of each inhibitor. The rate of protein synthesis was measured over the last 1 h of incubation using [3H]-Phe. Results are means ± SEM (n = 5 
independent preparations of cardiomyocytes). # p < 0.01, † p < 0.001 relative to controls, * p < 0.05, ‡ p < 0.001 relative to ET-1 or insulin alone (one-
way ANOVA with Tukey post-test).
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studies demonstrated that 4E-BP1 exhibits significant
phosphorylation in unstimulated cardiomyocytes, and
the degree of phosphorylation is increased in response to
insulin [18]. Furthermore, insulin increases the associa-
tion of Eif4e with 7-methylGTP-sepharose and would
thus be predicted to increase the rate of initiation of
translation for the 7-methylGTP cap structure.
Insulin or ET-1 increases the rate of protein synthesis
over the first 4 h of stimulation [18]. By pulse labelling
with [3H]-Phe for the final 1 h for periods up to 7 h, we
established that there was little increase in the rate of pro-
tein synthesis over the first hour, but the rate increased
significantly over the second hour with either insulin or
ET-1 and this was sustained for up to 7 h (Figure 1D).
Inhibiting ERK1/2 signaling with PD184352 (2 μM, a con-
centration that gives specific inhibition of this pathway
[22]; Figure 1E) had no significant effect on baseline pro-
tein synthesis or the increase in the rate of protein syn-
thesis induced by ET-1 or insulin between 1 and 2 h
(Figure 1F). Inhibiting PI3K signaling with 50 μM
LY294002 [23] (Figure 1E) inhibited baseline protein syn-
thesis to ~60% of control levels and inhibited the increase
in protein synthesis induced by ET-1 or insulin (Figure
1F). Consistent with our previous study over 4 h [18], this
suggests that PI3K plays a significant role in cardiomyo-
cyte protein synthesis. Rapamycin inhibited the phospho-
rylation of p70S6K (Figure 1E), but had no significant
e f f e c t  o n  b a s e l i n e  p r o t e i n  s y n t h e s i s .  H o w e v e r ,  i t  d i d
inhibit the increase induced by ET-1 and attenuated the
increase induced by insulin (Figure 1F).
Regulation of the global transcriptome by ET-1 or insulin
Previous studies demonstrated that almost all the
changes induced by ET-1 in the cardiomyocyte transcrip-
tome at 1 h (470 RNAs, n = 8) represent immediate early
genes [21]. Here, we compared the effects of ET-1 (100
nM) with insulin (50 mU/ml) on the global transcriptome
at 1 h. Using the same criteria (FDR < 0.05, >1.5-fold
change), expression of 428 and 45 probesets was signifi-
cantly changed by ET -1 or insulin, respectively (Figure
2A; Additional file 1). Of RNAs responsive to both ago-
nists (20 RNAs, 26 probesets), 4 were similarly upregu-
lated and 5 similarly downregulated (Group A, clusters (i)
and (ii)), whereas 11 were upregulated to a greater extent
by ET-1 (Group A, cluster (iii)). Only 18 RNAs (19 probe-
sets) were selectively regulated by insulin (13 upregulated
and 5 downregulated; Group B, clusters (iv) and (v)),
whereas 341 RNAs (402 probesets) were selectively regu-
lated by ET-1 [226 upregulated and 115 downregulated;
Group C, clusters (vi), (vii) and (viii)]. We previously
focused on Krüppel-like factors (Klfs) to validate ET-1-
responsive changes [21,24]. We therefore validated the
i n s u l i n  m i c r o a r r a y  d a t a  f o r  K l f s  b y  q P C R  ( F i g u r e  2 B ) .
Consistent with the microarray data, insulin promoted
transient increases in expression of Klf2, Klf10 and Klf16
mRNAs (maximal expression at 0.5 - 1 h), with downreg-
ulation of Klf15, Klf11 and Klf6 mRNAs (maximal down-
regulation by 2 h). These data indicate that, although
insulin does affect the global transcriptome, the response
to ET-1 is substantially greater with respect to relative
levels and numbers of changes.
RNA recruitment to cardiomyocyte polysomes
To study translational regulation, cardiomyocyte poly-
somes were prepared by sucrose density centrifugation
(Figure 3A) and RNA extracted. Equal amounts of
labelled cRNA from total or polysomal pools were analy-
sed using microarrays. Initially, we studied the baseline
differences between the total and polysomal RNA pro-
files. Polysomal RNA profiles of unstimulated cells
(serum-starved for 24 h) were notably different from total
RNA profiles and, using raw fluorescence values, expres-
sion of 6425 of the 15,446 probesets detected was signifi-
cantly different between the RNA pools (FDR < 0.05;
Figure 3B). Given the range of non-protein coding RNAs
that exist, this may not necessarily be considered as sur-
prising. However, of the top 10th percentile of detected
probesets (1655 probesets) that predominantly encode
mRNAs (Figure 3C, Additional file 2), 715 probesets
(~43%) were similarly expressed in total and polysomal
RNA pools (FDR > 0.05 and/or <1.25-fold difference), but
515 protein-coding mRNAs (~31%) exhibited >1.5-fold
difference (FDR < 0.05) in expression (Figure 3D). Differ-
ential expression did not correlate with raw fluorescence
values (Additional file 2), so the differences do not simply
reflect excessive levels of expression or saturation of the
microarray system. The data suggest that a significant
proportion of constitutively expressed mRNAs in cardio-
myocytes are translationally regulated and, in serum-
starved cells, there appears to be a reservoir in the total
RNA pool available for polysomal recruitment.
To identify RNAs with the greatest degree of differen-
tial expression between total and polysomal RNA pools,
the data were normalised to the gene median. Of RNAs
with substantial and significant differential expression
(FDR < 0.05, >3-fold difference; Additional file 3), 157
were non-protein coding RNAs for sequences in introns,
potential antisense sequences or probable microRNA
precursors (given the proximity to established microR-
NAs on the mouse genome) with a further 52 probesets
for RNAs associated with no established gene. As might
be expected, virtually all (there are 2 exceptions) were
preferentially detected in the total RNA pool. Of the 221
probesets encoding mRNAs, only 12 were preferentially
recruited to the polysomes. Interestingly, the most dis-
proportionately expressed mRNAs encoded α-myosin
heavy chain or β-myosin heavy chain, key myofibrillar
proteins, both of which were preferentially detected inMarkou et al. BMC Genomics 2010, 11:343
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Figure 2 Effects of ET-1 and insulin on the global cardiomyocyte transcriptome. A, Cardiomyocytes were exposed to 100 nM ET-1 or 50 mU/ml 
insulin (1 h) or left unstimulated (Control). Total RNA was extracted and the global transcriptome analysed using microarrays. Transcripts with signifi-
cant changes in expression (FDR < 0.05, >1.5-fold change) induced by either ET-1 or insulin relative to controls were clustered according to respon-
siveness to both agonists [Group A: (i) similar upregulation with both, (ii) similar downregulation with both, (iii) greater response to ET-1 than insulin], 
responsiveness to insulin alone [Group B: (iv) upregulated by insulin, (v) downregulated by insulin] or responsiveness to ET-1 alone [Group C: (vi) and 
(vii) upregulated by ET-1, (viii) downregulated by ET-1. Heatmaps represent the mean values of all probesets in each group with normalisation per 
gene to control values [Log2 scale; -2.0 (cyan) through 0 (black) to 2.0 (red)]. Histograms are means ± SEM for the RNAs in each group (numbers of 
transcripts in parentheses). B, Cardiomyocytes were exposed to insulin for the times indicated and mRNA expression of Klf2, Klf6, Klf10, Klf11, Klf15 and 
Klf16 measured by qPCR. Data were normalised to Gapdh. Solid circles represent qPCR data. Results are means ± SEM (n = 3 independent preparations 
of cardiomyocytes). * p < 0.05, # p < 0.01, † p < 0.001 relative to controls (one-way ANOVA with Tukey post-test). For comparison, microarray data are 
shown as open circles (means ± SEM, n = 4).
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Figure 3 Differential recruitment of cardiomyocyte RNAs to polysomes.Cardiomyocytes were serum-starved (20 h). Polysomes prepared by su-
crose density centrifugation. Total and polysomal RNA were extracted and analysed using microarrays. A, A254 profiles for sucrose density centrifuga-
tion. B, Heatmap of the mean raw fluorescence values for the 6425 probesets with significantly different expression in polysomal and total RNA pools 
in unstimulated cells [Log2 scale; 7 (cyan) through 10 (black) to 13 (red)]. C, Functional classification of top 10th percentile transcripts detected in car-
diomyocytes. D, Heatmap for the 515 probesets of the top 10th percentile with significantly different expression (FDR < 0.05, >1.5-fold difference) in 
polysomal and total RNA pools in unstimulated cells [Log2 scale; 9.5 (cyan) through 11.5 (black) to 13.5 (red)].
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total RNA. These data further suggest that cardiomyo-
cytes possess a reservoir of mRNAs.
Translational regulation in cardiomyocytes by insulin or ET-
1
Consistent with the effects on protein synthesis (Figure
1D), insulin or ET-1 (1 h) increased cardiomyocyte poly-
some content, as seen by the increase in A254 in heavier
sedimenting fractions (6 -11) and decrease in A254 in frac-
tions 1-4 (Figure 3A). Polysomal and total RNA profiles
were generated by hybridisation of equal amounts of
labelled cRNA to microarrays. To identify RNAs subject
to translational regulation by insulin or ET-1, the data for
each RNA pool were normalised to unstimulated controls
and the relative change in each pool (total and polysomal)
was assessed independently. We subsequently compared
the degree of change in total vs polysomal RNA. Thus,
probesets were selected with >1.25-fold change in total or
polysomal RNA relative to controls, and filtered on statis-
tical significance (FDR < 0.05). Potential translationally-
regulated RNAs were then selected with statistically-sig-
nificant changes only in polysomal RNA (Group I RNAs)
or only in total RNA (Group II RNAs) and with expres-
sion ratio (fold change in polysomal RNA:fold change in
total RNA or vice versa) >1.2. We considered there was
insufficient evidence for translational regulation of
remaining RNAs (Group III, FDR > 0.05 and/or expres-
sion ratio < 1.2).
Approximately 56% of insulin-responsive and ~35% of
ET-1-responsive transcripts were classed as Group I
RNAs (265 RNAs with insulin; 112 RNAs with ET-1) or
Group II RNAs (137 RNAs with insulin; 366 RNAs with
ET-1) (Figure 4; Additional files 4 and 5). With respect to
function, proteins associated with signaling/trafficking or
transcriptional regulation, or RNAs for hypothetical pro-
teins or transcripts of no known function were prevalent
in all groups (Figure 4, B and 4D). However, insulin par-
ticularly increased polysomal association of mRNAs for
proteins associated with protein synthesis (Figure 4, A
and 4B; Group I RNAs), including TOP mRNAs for 47
cytosolic ribosomal proteins, Eif3f and Eef1b2 (Addi-
tional files 4 and 6). The TOP mRNA for Rpl39 was the
only one to be decreased in cardiomyocyte polysomes in
response to insulin. We validated the changes for two
ribosomal protein mRNAs, Rps3 and Rps6 (Figure 5A) by
qPCR, demonstrating selective upregulation in the poly-
somes in response to insulin. Consistent with this, abso-
lute levels of Rps3 and Rps6 proteins (Figure 5B), and 18S
and 28S RNAs (Figure 5C and 5D) were increased.
We identified all probesets for established TOP
mRNAs encoding ribosomal proteins, elongation factors
and Eif3e and Eif3h [5], and analysed the response to
insulin. Of 79 ribosomal protein mRNAs, all but 10 were
significantly increased in the insulin-responsive trans-
latome and only 3 (Rpl36, Rpl39 and Rpl7l1) were not
upregulated to any degree (Additional file 6). Eif3e and
Eif3h mRNAs were also significantly upregulated in the
insulin-responsive translatome and, of the elongation fac-
tors, Eef1b2 mRNA was the only elongation factor mRNA
to be significantly upregulated (Additional file 6). Previ-
ous work suggests that ET-1 also increases translation of
TOP mRNAs in feline cardiomyocytes as demonstrated
by an increase in Rpl32 mRNA recruitment to polysomes
[20]. Our data indicated that ET-1 did increase recruit-
ment of mRNAs for Rpl32 and other ribosomal proteins
to rat neonatal cardiomyocyte polysomes, but this was
not as great as that induced by insulin, nor was it statisti-
cally significant (Additional file 6).
Informatics analysis of 5' UTRs of mRNAs recruited to 
polysomes in response to insulin
113 of 132 RNAs significantly upregulated by insulin in
the translatome but not the transcriptome encoded
established proteins, 49 of which were established TOP
mRNAs (see above). This raises the question of how
many other mRNAs in this group also contain a TOP
sequence. Since few transcriptional start sites (TSSs) have
been mapped for the rat genome, we identified 5' UTR
sequences for mRNAs for the mouse orthologs using the
FANTOM3 CAGE (cap analysis of gene expression) data-
base with support from NCBI databases and the Database
of TSSs (DBTSS). We then identified 5' sequences of rat
mRNAs (often predicted) from the NCBI rat genome
database to confirm sequence conservation between spe-
cies. With this approach we identified 5' UTR sequences
for all but 6 mRNAs (Hnrph3, N6amt2, Ptrh1, Tac2,
Thap6, Tmed5) in the insulin-responsive cardiomyocyte
translatome. All ribosomal protein mRNAs identified
were TOP mRNAs (Additional file 6), with a single excep-
tion, Rpl7l1. Interestingly, even though Rpl39 mRNA was
downregulated in the translatome the 5'UTR contained a
TOP sequence. Of other established mRNAs recruited to
cardiomyocyte polysomes in response to insulin, Eif3e,
Eif3f, Eif3h, Eef1b2, Gnb2l1 (also known as RACK1) and
Npm1 were verified as TOP mRNAs (Additional file 6).
W e  e x a m i n e d  5 '  U T R s  f o r  o t h e r  m R N A s  s e l e c t i v e l y
recruited to cardiomyocyte polysomes by insulin. Atg12,
Atp5g2, Ccnj, Cnih, Gltscr2, Naca, Pfdn5 and Rbms2
were identified as probable TOP mRNAs on the basis of
the TSS for mouse transcripts and homology with the rat
genome (Table 1). Brpf1, Ilk, Plekhh3, Snrpd2 and Zfp110
mRNAs were identified as potential TOP RNAs although
mouse and rat 5' UTRs have less identity and not all start
with C (Additional file 6). We could not identify TOP
sequences for 49 mRNAs and, although most contain
polypyrimidine tracts, uORFs, GC tracts or untranslated
5' exons within the 5' UTR, there were no consistent fea-
tures (Additional file 7). A recent bioinformatics studyMarkou et al. BMC Genomics 2010, 11:343
http://www.biomedcentral.com/1471-2164/11/343
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Figure 4 Translational regulation of cardiomyocyte transcripts by insulin or ET-1.Cardiomyocytes were exposed to 100 nM ET-1 or 50 mU/ml 
insulin (1 h) or were left unstimulated. Polysomes were prepared by sucrose density centrifugation. Total and polysomal RNA were extracted and anal-
ysed using microarrays. RNAs with significant changes in expression (FDR < 0.05, >1.25-fold change) induced by insulin (A and B) or ET-1 (C and D) in 
either total or polysomal RNA pools were identified and clustered according to regulation in polysomal RNA only (Group I; FDR < 0.05 in polysomal 
RNA only and expression ratio >1.2 for polysomal RNA:total RNA), regulation in total RNA only (Group II; FDR < 0.05 in total RNA only and expression 
ratio >1.2 for total RNA:polysomal RNA) or similar regulation in both (Group III; FDR < 0.05 in both polysomal and total RNA, or expression ratio <1.2). 
A, Heatmap for insulin-regulated probesets showing the mean values of all probesets in each group with normalisation per gene to control values 
[Log2 scale; -0.7 (cyan) through 0 (black) to 0.7 (red)]. C, Heatmap for ET-1-regulated probesets showing the mean values of all probesets in each group 
with normalisation per gene to control values [Log2 scale; -1.5 (cyan) through 0 (black) to 1.5 (red)]. B and D, Functional classification of the RNAs illus-
trated in panels A and C, respectively, showing the numbers of RNAs in each group (numbers of upregulated and downregulated RNAs are represent-
ed in red and cyan, respectively).
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identified an additional 167 potential TOP mRNAs [11].
We mined our data for these, but only Impdh2 and Eif3e
were significantly changed with another 28 being
increased >10% albeit in the absence of statistical signifi-
cance (Additional file 8). The majority showed no change
in expression in cardiomyocyte polysomes in response to
insulin although, given the recruitment of ribosomal pro-
tein mRNAs to cardiomyocyte polysomes, we are confi-
dent that a signaling pathway(s) for regulation of TOP
mRNAs was operative.
ET-1 promoted some increase in recruitment to cardio-
myocyte polysomes of mRNAs encoding ribosomal pro-
teins (Additional file 6), suggesting there may be an effect
on TOP mRNAs. We therefore examined the 5' UTR
sequences of mRNAs with significant and selective
recruitment to cardiomyocyte polysomes in response to
Figure 5 Insulin increases ribosomal content in cardiomyocytes. Cardiomyocytes (4 × 106 cells per sample) were exposed to 50 mU/ml insulin or 
were left unstimulated. A, RNA was extracted from cardiomyocytes exposed to insulin for 1 h. Rps3 and Rps6 mRNA expression was measured by qPCR 
using the absolute quantification protocol. Results are expressed relative to unstimulated controls and are means ± SEM (n = 8 independent prepa-
rations of cardiomyocytes). * p < 0.05 relative to controls (Student's t-test). B, Protein extracts from cardiomyocytes exposed to insulin for 0, 2 or 4 h 
were immunoblotted with antibodies to Rps3 (upper panel) or Rps6 (center panel). * p < 0.05 relative to controls (Student's t-test). C and D, RNA was 
extracted and analysed for 18S and 28S ribosomal RNA content using an Agilent Bioanalyser. Representative traces are shown in panel C for unstim-
ulated (Control) cells and cells exposed to insulin for 1 h. The areas under the 18S and 28S peaks were integrated and the results are shown in panel 
D as means ± SEM (n = 3 independent preparations of cardiomyocytes). * p < 0.05, # p < 0.01 relative to controls (one-way ANOVA with Tukey post-
test).
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ET-1 (Additional file 5). Of the 30 mRNAs for which we
could determine the potential TSS, 6 were also regulated
by insulin (Afg3l2, Azi2, Ccnl2, Eef2k, Sfrs5, Slc25a33)
but did not possess a TOP sequence, and there were no
consistent features for the remaining 24 mRNAs (Addi-
tional file 9).
Discussion
Transcription vs translation in cardiomyocytes
Most transcriptomics studies focus on global changes in
RNA expression in response to specific stimuli or in spe-
cific disease states. However, analysis of mRNAs associ-
ated with polysomes provides further insight into
translational regulation. Studies in yeast [25,26], trans-
formed cancerous cells [8-10] and primary T cells [6,7] all
suggest that, in steady-state (usually starved) cells, there
is disparity between global transcript expression and
translation of specific mRNAs. Our data with unstimu-
lated (serum-starved) cardiomyocytes (Figure 3, B - D)
are consistent with this and, although many RNAs in the
global transcriptome are non-protein coding and may not
n e c e s s a r i l y  b e  e x p e c t e d  t o  b e  r e c r u i t e d  t o  p o l y s o m e s ,
over 30% of the most abundant cardiomyocyte mRNAs
were differentially expressed in global and polysomal
pools (Figure 3, B - D). Many of the most disproportion-
ately expressed mRNAs in the global RNA pool encoded
cytoskeletal/myofibrillar proteins. In response to hyper-
trophic stimulation, these may be rapidly recruited to
polysomes for translation, thus initiating hypertrophic
growth in the absence of further increases in transcript
levels.
A further question relates to the degree of translational
regulation following exposure to growth stimuli. Since
the relative effect on transcriptional vs translational regu-
Table 1: Identification of novel TOP mRNAs.
Gene Symbol Polysome RNA Total RNA 5' UTR
Atg12 1.28 1.03 Mouse:CTTCCGCCGCCGCCTCTCAGCAAGCAAAGATG
Rat: CTTCCGCCGTCGACGCTCAGCAAGCAAGATG
Atp5g2 1.26 1.00 Mouse:CCCTCTCTGTCTTCTCTGCCCTGGGAGCAGCCCTCCTGCCTCGGCCCCT
CACCCCTGAAAATG
Rat: CCCTCTCTGTCTTCTCTACCCTGGGAGCAGCTCTTCTGCCTTTGCCCCTC
ACCCCTGAAAAATG
Ccnj 1.52 1.20 Mouse:CTTCCAGACTGAAGTTGCGGCGTCTGGCCGGGCGCACCTCCGGCTTCCA
TG
Rat: CTTCCAGACTGAAGTTGCGGCGTCTGGCTGGGCGCGCCTCCGGCTTCCATG
Cnih 1.25 1.02 Mouse:CTTTCTCCGCTGGCCCCGGCGCGCCCGGCAGCTCCTCCCCGGCCATG
Rat: CTTTCTCCGCTGGCCCCGGCGCGCCCGGCAGCTCCTCCCCGGCCATG
Gltscr2 1.28 0.91 Mouse:CTTCCTTTAAGAAGATG
Rat: CTTCCTTTAAGAAGATG
Naca 1.25 0.96 Mouse:CTCTTTCTGCCGCCATCTTGGTTCCGTGATCTCCGCACAAAATG
Rat: CTCTTTCCACCGCCATCTTGGTTCCGTGTTCTCCGCACAAAATG
Pfdn5 1.28 0.90 Mouse:CTTCCTCTTCGGCAGTCCTCCTTCCCAACATG
Rat: CTTCCGCTTCGGCATTCCTCCTTCCCAACATG
Rbms2 1.27 0.96 Mouse:CTCCCTCCCTTTCCTTCACTCTCTTCTTTCTCTCTCTCAGCTCCGTAAC
AGTAAAGAAAAAATG
Rat: CTCCCTCCCTTTCCTTCACTCTCTTCTTTCTCTCTCTCAGCTCCGTAACA
GTAAAGAAAAAATG
Total and polysomal RNA from cardiomyocytes exposed to insulin (50 mU/ml, 1 h) or unstimulated cardiomyocytes (controls) were analysed 
using microarrays. Probesets corresponding to mRNAs with >1.25-fold increase in expression (FDR < 0.05) were identified. Results are the 
mean fold change in insulin stimulated samples relative to controls. Mouse and rat 5' UTR sequences were identified. The TOP sequence is in 
bold italics. Accession numbers are provided in Additional data file 6.Markou et al. BMC Genomics 2010, 11:343
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lation is likely to depend on the intracellular signaling
pathways activated by specific stimuli, we compared ET-1
(potent activation of ERK1/2 with minimal activation of
PI3K and PKB/Akt) and insulin (potent activation of
PI3K and PKB/Akt with minimal activation of ERK1/2)
[19]. Whereas ET-1 drives a substantial response in the
global transcriptome (Figures 2 and 4), a large proportion
of which requires ERK1/2 signaling [21], insulin had a rel-
atively minor effect on global RNA expression, suggesting
that PI3K signaling through PKB/Akt does not substan-
tially affect transcription even though PKB/Akt phospho-
rylates, for example, Forkhead transcription factors that
are then inactivated [17]. To gain insight into the insulin
response and regulation of translation, it was necessary to
examine smaller relative changes (>1.25-fold; Figure 4).
This suggests that effects on translation of individual
transcripts and of insulin generally are relatively subtle.
Interestingly, insulin had a greater translational effect on
recruiting transcripts to polysomes rather than a bias
away from the polysomes (Figure 4, A and 4B, Group I
transcripts), whereas ET-1 had a greater effect on down-
regulated transcripts that were preserved in the poly-
somal fraction (Figure 4, C and 4D, Group II transcripts).
In interpreting the data from this study, it should be
noted that (as is usual for microarray experiments) equal
amounts of RNA from total and polysomal pools were
hybridized to the microarrays. Given that the data nor-
malization was to the values of unstimulated cells and
that insulin and ET-1 each increased the absolute amount
of polysomal RNA (Figure 3A), it may be viewed that a
g r e a t e r  n u m b e r  o f  c e l l s  w e r e  r e p r e s e n t e d  f r o m  t h e
unstimulated samples compared with those from samples
stimulated with insulin or ET -1. As a consequence, the
degree by which transcripts were increased in polysomal
RNA by insulin or ET -1 and the number of transcripts
decreased in polysomal RNA may have been underesti-
mated. Our analysis is therefore likely to be conservative
in relation to both these aspects. Nevertheless, since the
criteria for analysis were identical for both agonists (using
a relatively low level for relative fold change in combina-
tion with statistical evaluation) and both promoted a sim-
ilar increase in cardiomyocyte polysomes, the data
reliably highlight the differential effects of insulin and ET-
1 on translational regulation in cardiomyocytes.
Translational regulation by insulin and identification of 
TOP mRNAs
It is almost 20 years since the TOP motif was identified in
mammalian mRNAs for ribosomal proteins [27], and this
is probably the most well-established feature of mRNAs
that are translationally regulated in response to nutrients
or growth stimuli [28]. The best characterized TOP
mRNAs encode ribosomal proteins and, although others
have been identified, most are associated with the trans-
lational apparatus [5]. The prevalence of TOP mRNAs
and the extent to which this mechanism accounts for
translational regulation is still debated. Since PI3K signal-
ing and mTOR are particularly implicated in the TOP
mRNA response [12], we focused on the cardiomyocyte
response to insulin. As expected, insulin increased
recruitment of established TOP mRNAs to cardiomyo-
cyte polysomes. Although we identified a few probable/
possible TOP mRNAs, we could find no evidence for
TOP sequences for ~43% of mRNAs we identified as sig-
nificantly increased in the insulin-responsive cardiomyo-
cyte translatome. There are problems in identifying TSSs
and many genes are not well-studied, so we cannot be
certain that the latter group are not subject to alternative
splicing or possess alternative promoters that may pro-
duce a 5' TOP sequence. However, the data suggest that
there may not be many more TOP mRNAs to be identi-
fied. The mRNAs with no apparent TOP sequence pos-
sess a variety of features in the 5' UTR that indicate
potential for translational regulation. With no consistent
features, further studies will need to focus on individual
mRNAs, first to confirm the 5' UTR sequence and,
assuming TOP sequences are not identified, to establish
the mechanisms of regulation.
With the vast amount of genome sequence data avail-
able, it might be expected that identification of TOP
mRNAs should be relatively trivial but, even for human
and mouse genomes, the TSS is often not well-defined,
partly because of alternative promoters and alternative
splicing of non-protein-coding first exons. The bioinfor-
matics approach of Yamashita et al. [11] utilised a data-
base of TSSs to define all potential TOP mRNAs for the
human genome. Surprisingly, we found very few of these
mRNAs in our insulin-responsive pool of transcripts
recruited to cardiomyocyte polysomes (Additional files 6
and 8). Yamashita et al. used a phorbol ester for experi-
mental validation and demonstrated polysomal recruit-
ment of 41 of 83 candidate TOP RNAs tested. Phorbol
esters, like ET-1, potently activate ERK1/2 signaling in
cardiomyocytes [16], but we detected no preferential
recruitment of the candidate TOP transcripts to cardio-
myocyte polysomes in response to ET-1 either (Addi-
tional files 8 and 9). This perhaps highlights the necessity
(currently) for an experimentally driven approach.
Protein kinase signaling and translational regulation
PI3K signaling and mTOR are implicated in the regula-
tion of TOP mRNAs and mRNA translation in general
[1]. Our data are consistent with this. Thus, basal cardio-
myocyte protein synthesis and PKB/Akt phosphorylation
[18], was attenuated by inhibiting PI3K with LY294002
(Figure 1, E and 1F) indicating that, even in the basalMarkou et al. BMC Genomics 2010, 11:343
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state, turnover of phosphatidylinositol 3,4,5 trisphos-
phate plays an important maintenance role. Furthermore,
the increase in protein synthesis induced by ET-1 or insu-
lin was attenuated by LY294002 or rapamycin (Figure 1F).
Our aim was to highlight differential signaling by ET-1
and insulin in relation to protein synthesis rather than
dissect the involvement of signaling pathways in transla-
tional regulation per se. Thus, ET-1 potently activated
ERK1/2 rather than PKB/Akt whereas insulin activated
PKB/Akt rather than ERK1/2 (Figure 1A), but the path-
ways appear to converge and either stimulus promoted
phosphorylation of mTOR, p70S6Ks and Rps6 (Figure
1B). The data are consistent with studies in other cells
that implicate ERK1/2 signaling in the regulation of
mTOR, p70S6Ks and Rps6 in addition to PI3K (see, for
example, [29-31]), and both ET-1 and insulin promote
phosphorylation of mTOR in feline cardiomyocytes [20].
However, the significance of this for translational regula-
tion of TOP mRNAs or, indeed, translational regulation
by any other mechanism is not clear.
Regardless of the signaling mechanism, there was little
similarity in the responses to ET-1 and insulin, both with
respect to the global transcriptome and the translatome
(Figure 4, Additional files 4 and 5). This contrasts with a
study in feline cardiomyocytes suggesting that either
stimulus promotes recruitment of TOP mRNAs to poly-
somes for translation [20]. It should perhaps be consid-
ered that only Rpl32 mRNA was studied, as an example of
a TOP mRNA, and the global picture was not defined. In
our study, ET-1 did promote some increase in recruit-
ment of TOP mRNAs for ribosomal proteins to cardio-
myocyte polysomes (Additional file 6) but, overall, the
response was less than that of insulin. Potentially, the
degree of the response correlates with the lesser activa-
tion of mTOR by ET-1 than insulin (Figure 1, B and 1C),
but we have little understanding of the mTOR signaling
pathway in cardiomyocytes on which to base such a
claim.
Though outside the scope of this study, further work is
clearly required to establish the mechanisms by which
insulin or ET-1 influence mRNA recruitment to cardio-
myocyte polysomes. Given the likely importance of
mTOR and the discrepancies in the literature with
respect to mTOR regulation and sensitivity or otherwise
to rapamycin [1,32,33], perhaps the most immediate
focus should be the rapamycin sensitivity (or otherwise)
of polysomal recruitment of TOP vs non-TOP mRNAs in
the cardiomyocyte response to insulin or ET-1. However,
more fundamental studies are also required simply to
understand the PI3K signaling pathway in cardiomyo-
cytes. Some of the important questions to be addressed
r e l a t e  t o  c o m p a r t m e n t a l i s a t i o n  o f  s i g n a l i n g  e v e n t s  t o
establish whether, for example, activation of PI3K and/or
mTOR by insulin is confined to a specific location and
whether mTOR activated by ET-1 constitutes a distinct
pool. Such spatial organisation could explain differential
effects of the two stimuli despite a similar global level of
mTOR activation. Even more fundamentally, perhaps it is
worth noting that although PKB/Akt and mTOR are well-
established effectors of PI3K signalling and most studies
use PKB/Akt as an indicator of PI3K activation, PI3K is a
family of enzymes with many lipid (and potentially pro-
tein) substrates that seem likely to signal through a range
of effectors. This area is largely uninvestigated in cardio-
myocytes and is underinvestigated in other cells, but
future studies such as these may prove essential in under-
standing the role of PI3K in translational regulation.
Conclusions
In summary, ET-1 substantially affects global transcript
expression whereas insulin has a more subtle effect both
in terms of relative changes and breadth of the response,
and effects of either ET-1 or insulin on RNA recruitment
to polysomes are more subtle with differential effects of
the two agonists on specific transcripts. Notably, insulin
stimulates recruitment of established TOP mRNAs to
cardiomyocyte polysomes. Although we identified some
novel TOP mRNAs, we could not identify a TOP
sequence in the 5' UTRs of ~43% of the mRNAs for estab-
lished proteins with selective upregulation in the insulin-
responsive cardiomyocyte translatome. This suggests that
the TOP mRNA response is largely confined to mRNAs
encoding components of the translational apparatus, and
other mechanisms of translational regulation operate in
parallel. We suggest that these differences result from
activation of different signaling pathways and may
account for the overt hypertrophy induced by ET-1 com-
pared with a "maintenance" effect of insulin. However,
with the complexities of the signaling and transcriptional
pathways with signal integration at specific nodes, fur-
ther studies are clearly required to dissect the underlying
mechanisms.
Methods
Primary cultures of neonatal rat ventricular myocytes and 
preparation of cardiomyocyte polysomes
Cardiomyocytes were cultured from 1-3 day neonatal rat
hearts as previously described [21]. Cells were plated at
confluence on Primaria tissue culture dishes in 15% (v/v)
fetal calf serum (18 h) and serum was withdrawn (24 h)
prior to stimulation. Cardiomyocytes were left unstimu-
lated (Controls), exposed to 100 nM ET-1 (Bachem), 50
mU/ml insulin (Actrapid® Novo Nordisk A/S, Denmark),
1 μM rapamycin (Calbiochem®, Merck Chemicals), 50 μM
LY294002 (Enzo Life Sciences) or 2 μM PD184352 (Enzo
Life Sciences) or exposed to ET-1 or insulin followingMarkou et al. BMC Genomics 2010, 11:343
http://www.biomedcentral.com/1471-2164/11/343
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pre-treatment (10 min) with rapamycin, LY294002 or
PD184352. Cardiomyocyte polysomes (16 × 106 cells per
sample) were prepared by sucrose density centrifugation
as previously described [21]. Fractions (12 in total) were
collected by upward displacement whilst monitoring
absorbance at 254 nm. Fractions 6-11 were pooled for the
preparation of polysomal RNA.
Immunoblotting
Immunoblotting of cardiomyocyte nuclear extracts was
performed essentially as described [34]. For all analyses
other than total/phosphorylated mTOR, proteins (4 × 105
cells for phosphorylated and total ERK1/2 and PKBAkt
blots; 2 × 105  cells for phosphorylated and/or total
p70S6K, Rps3 and Rps6) were separated on 10% (w/v)
polyacrylamide gels with electrophoresis for 45 min at
200 V. Proteins were transferred to nitrocellulose using
standard transfer buffer (25 mM Tris, 192 mM glycine,
20% (v/v) methanol). For mTOR, proteins (2 × 105 cells)
were separated on 8% (w/v) polyacrylamide gels with
electrophoresis at 100 V until the dye front reached the
bottom of the gel followed by 200 V for 2 h. Proteins were
transferred to nitrocellulose using transfer buffer for high
molecular weight proteins (48 mM Tris, 39 mM glycine,
1.3 mM SDS). Primary antibodies [phospho-ERK1/2 (cat.
no. 4377), phospho(Ser473)-PKB/Akt and phos-
pho(Thr308)-PKB/Akt (cat. nos. 9271 and 9275, respec-
tively; these antibodies were used in combination),
phospho(Ser2448)-mTOR (cat. no. 2971), total mTOR
(cat. no. 2983), phospho(Ser235/236)-Rps6 (cat. no.
4858), Rps6, total Rps3 (cat. nol. 2579)] were from Cell
Signaling Inc. and were used at 1/1000 dilution. Second-
ary antibodies conjugated to horseradish peroxidase were
from Dako and used at 1/5000 dilution.
Protein synthesis assays
To study the rate of protein synthesis at specific times,
myocytes (2 × 106 cells per 35 mm dish) were incubated
100 nM ET-1 or 50 mU/ml insulin for a total of 1, 2 or 7 h
with addition of L-[2,3,4,5,6-3H]-Phe (American Radiola-
beled Chemicals Inc.) for the last 1 h of the incubation.
For inhibitor studies, myocytes were exposed to each
inhibitor alone (50 μM LY294002, 1 μM rapamycin, or 2
μM PD184352), ET-1 or insulin, or ET-1 or insulin in the
presence of each inhibitor for a total of 2 h with addition
of L-[2,3,4,5,6-3H]-Phe for the last 1 h of the incubation.
Myocytes were washed (PBS, 1 ml, 4°C) and scraped into
1 ml 0.2 mM NaOH. A sample (15 μl) was taken to deter-
mine total protein (Biorad Bradford assay [35]). Bovine
serum albumin (0.1 ml, 100 mg/ml) was added to the
remaining sample, proteins were precipitated with 10%
(w/v) trichloroacetic acid (6 ml) and samples were centri-
fuged. Precipitates were washed [10% (w/v) trichloroa-
cetic acid (3 × 5 ml)], NaOH added (10 μl, 10 M), and the
pellets were dissolved in 1.8 ml Soluene (Perkin Elmer
UK) before scintillation counting using Ultima Gold scin-
tillation fluid (Perkin Elmer UK). Experiments were per-
formed in duplicate, the mean values were taken and
corrected according to total protein. The data are pre-
sented as means ± SEM of these values.
RNA preparation and microarray analysis
The total and polysomal RNA samples for controls and
ET-1 (1 h) from our previous study [21] were hybridised
to Affymetrix rat genome 230 2.0 microarrays simultane-
ously with samples treated with insulin (50 mU/ml, 1 h).
Here, the full dataset was analysed using GeneSpring GX
10.0.2 (previously, we used GeneSpring GX 7.3.1).
Total RNAs (4 × 106 cells per sample) and polysomal
RNAs (16 × 106 cells per sample) were prepared from
unstimulated myocytes and myocytes exposed to ET-1
(100 nM, 1 h) or insulin (50 mU/ml, 1 h). RNAs were pre-
pared from 12 separate myocyte preparations, individual
samples were generated by combining equal amounts of
RNA from three myocyte preparations and four sets of
samples were hybridised to individual microarrays. RNA
preparation and microarray hybridizations were per-
formed as previously described [21]. The data are avail-
able from ArrayExpress (accession numbers: E-MIMR-
681 for ET-1 data; E-MEXP-2527 for insulin data; the
controls are included in each dataset). The .CEL files
were imported into GeneSpring GX 10.0.2 for analysis
using MAS 5.0 summarisation with normalisation to
unstimulated control samples (analysis of changes
induced by ET-1 or insulin), no baseline normalisation
(comparison of raw expression values in total RNA vs
polysomal RNA in control cells) or normalisation to gene
median (identification of differential representation of
transcripts in total and polysomal RNA pools in control
cells). A confidence filter was applied (P/M in 100% of
any condition; >50 raw value), and probesets selected
according to relative level of expression followed by sta-
tistical testing (one-way ANOVA with Tukey post-test or
t-test as indicated) with FDR < 0.05 (Benjamini and
Hochberg correction for multiple testing). For agonist-
responsive RNAs, supervised clustering was performed
according to relative changes in expression (upregulation
or downregulation by ET-1 and/or insulin). Heatmaps
were generated with GeneSpring GX 10.0.2 using a
Euclidean complete correlation. To confirm statistical sig-
nificance for cluster sets, normalised values were
exported and analysed by GraphPad Prism 4.
Bioinformatics
All gene identities were confirmed by BLAST search of
the probeset sequences using the Entrez nucleotide data-Markou et al. BMC Genomics 2010, 11:343
http://www.biomedcentral.com/1471-2164/11/343
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bases [36]. BLAST searches for unassigned sequences
were performed against the rat genome [37] and, since
the rat genome is still less well annotated, the mouse
genome [38] (cross-species megaBLAST). Genes were
classified as far as possible using GeneOntology classifi-
cations associated with rat, mouse and human orthologs
[39], taking into account both probable Function and Pro-
cess. For genes with conflicting potential functions, fur-
ther literature searches were performed to ascertain
probable biochemical function. Genes were grouped
according to their biochemical function in the cell. Tran-
scriptional start sites for mouse orthologs were deter-
mined using the FANTOM3 database [40], selecting for
RIKEN clones with confirmation of a complete 5' UTR.
For mouse and human orthologs, we also used the Data-
base of Transcriptional Start Sites [41]. The predicted
minimum fold energy of 5'UTR sequences was deter-
mined using the Vienna RNAfold WebServer [42].
Because of the large number of pseudogenes for ribo-
somal proteins in mammalian genomes [43], in some
cases the gene is not correctly identified on the rat
genome. In these cases, we identified the correct gene by
its exon structure and position relative to adjacent genes
identified on the mouse and human genomes.
Quantitative reverse transcription-polymerase chain 
reaction (qPCR)
Primers for qPCR were designed for established genes
using published rat sequences and PrimerExpress soft-
ware for Real-Time PCR (version 3.0; Applied Biosys-
tems) (Table 2). Where possible, these were designed
across an exon boundary. cDNA was prepared by reverse
transcription of RNA samples and qPCR performed
using a 7500 Real-Time PCR System (Applied Biosys-
tems). A master-mix with (per reaction) 12.5 μl Sybr-
Green Jump Start Taq Readymix (Sigma-Aldrich) and 5 μl
oligonucleotides (5 pmol each of forward and reverse
primers) was aliquoted into Optical 96-well reaction-
plates (Applied Biosystems), and cDNA template added
(7.5 μl, 1/15 dilution in water). PCR conditions were 50°C
for 2 min, 95°C for 10 min, followed by 40 cycles of 95°C
for 15 s and 59°C for 60 s. Dissociation curve analysis was
performed to check for aberrant amplification products.
An absolute quantitation protocol was used and data
were normalised to Gapdh where indicated.
18S/28S rRNA quantification by Agilent Bioanalyser
Quantitative analysis of 18S/28S ribosomal RNA was per-
formed with an Agilent 2100 Bioanalyser using the RNA
6000 Nano kit (Agilent Technologies, Palo Alto, CA,
USA). Total RNA was prepared according to the Agilent
2100 Bioanalyser protocol, loaded into the NanoChip and
processed for 30 min. Electropherograms were analyzed
according to the manufacturer's protocol and the 18S and
28S ribosomal peak areas were integrated.
Statistical analysis
Statistical analysis of microarray data was performed
using GeneSpring GX 10.0.2 (one-way ANOVA with
Tukey post-test or t-test as indicated) using FDR < 0.05
(Benjamini and Hochberg correction for multiple test-
ing). Statistical analysis of qPCR, protein synthesis and
immunoblotting data was performed using GraphPad
Prism 4.
List of abbreviations
ERK: Extracellular signal-regulated kinase; mTOR: mam-
malian target of rapamycin; mTORC: mTOR complex;
p70S6K: p70 ribosomal S6 kinase; p90RSK: p90 ribo-
somal S6 kinase; PI3K: phosphatidylinositol 3' kinase;
TOP: terminal oligopyrimidine tract; uORF: upstream
open reading frame; UTR: untranslated region
Table 2: Primers used for qPCR.
Gene Accession no. Size (bp) Forward primer Reverse primer
Klf2 NM_001007684 96 CACACAGGTGAGAAGCCTTATCAT (874-897) CCGTGTGCTTGCGGTAGTG (952-970)
Klf6 NM_031642 89 GCTCCCACTTGAAAGCACATC (641-661) TTCTTGCAAAACGCCACTCA (710-729)
Klf10 NM_031135 149 CCATGAGCTGCGACTGGAA (183-201) TAAGGTGGAGTCAAACAGAATGCT (307-331)
Klf11 NM_001037354 85 CCTGATCTACCAAAGGACTTCCA (311-333) CTCATGGAGCCAACAGGGA (377-395)
Klf15 NM_053536 65 TGCGGCTGGAGGTTTTCA (1347-1364) TTCACACCCGAGTGAGATCGT (1391-1411)
Klf16 NM_001127604 79 TCACACCTGCGGACTCACA (516-534) CGGAACGGGCGAACTTCT (577-594)
Rps3 NM_001009239 94 AAAGTGGCCACAAGAGGTCTGT (280-301) CATAGCAGGCCCTTCGAACT (354-373)
Rps6 NM_017160 82 AAGGTAAGAAGCCCAGGACCAA (509-530) ATACGTCGGCGTTTGTGTTG (571-590)
mRNA sequences (accession numbers provided) for established genes were obtained from the Rat Genome Database (http://rgd.mcw.edu, 
viewed at http://www.ncbi.nlm.nih.gov/entrez). Nucleotide positions are shown in parentheses for each primer.Markou et al. BMC Genomics 2010, 11:343
http://www.biomedcentral.com/1471-2164/11/343
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Additional file 1 Regulation of the cardiomyocyte global transcrip-
tome by ET-1 or insulin (Microsoft Word Table). Cardiomyocytes were 
unstimulated (control), or exposed to 100 nM ET-1 or 50 mU/ml insulin (1 
h). Total RNA expression was determined using microarrays. Transcripts 
were identified with significant changes in expression (>1.5-fold change 
induced by ET-1 or insulin relative to controls; FDR < 0.05, * ET-1 vs control; # 
Insulin vs control; † ET-1 vs insulin, one-way ANOVA with Tukey post-test 
and Benjamini-Hochberg FDR correction). Mean raw values are given for 
controls with the mean change relative to controls for ET-1 or insulin (n = 4). 
For transcripts represented by more than one probeset, the probesets and 
corresponding raw values are listed with the average of the mean relative 
change. RNA responses are clustered according to up- or down-regulation, 
and the effect of ET-1 and/or insulin. Clusters (i) - (viii) correspond to the 
summarised data in Figure 2A of the associated manuscript. Clusters are 
colour-coded according to response to ET-1 and insulin (green), ET-1 only 
(yellow) or insulin only (cyan). AS, Antisense.
Additional file 2 Functional classifications of the top 10th percentile 
RNAs identified in neonatal rat cardiomyocytes (Microsoft Word 
Table). Total and polysomal RNA from unstimulated neonatal rat cardio-
myocytes (serum-starved, 20 h) were analysed using microarrays. Results 
are the mean raw fluorescence values (n = 4). For transcripts represented by 
more than one probeset, the probesets and mean corresponding raw val-
ues are listed. Differential expression in polysome vs total RNA was analysed 
by t-test with Benjamini-Hochberg FDR correction (*p < 0.05). RNAs are 
grouped according to general functional categories (summarised in Figure 
3C of the associated manuscript) with detailed functions within the Table.
Additional file 3 Differential expression of cardiomyocyte transcripts in 
polysomal and total RNA (Microsoft Word Table). Total and polysomal RNA 
from unstimulated neonatal rat cardiomyocytes were analysed using microar-
rays. The data were normalised to the gene median. Transcripts with differential 
expression in total and polysomal RNA pools were identified (t-test with Benja-
mini-Hochberg FDR correction p < 0.05; >3-fold difference). Mean raw fluores-
cence and normalised values are given (n = 4). For transcripts represented by 
more than one probeset, the probesets and mean corresponding raw values 
are listed. RNAs are listed according to relative expression in polysomal or total 
pools and whether they are protein-coding, non-protein-coding or associated 
with no known gene. AS = Antisense.
Additional file 4 Regulation of polysomal and total RNA expression in 
cardiomyocytes in response to insulin (Microsoft Word Table). Neona-
tal rat cardiomyocytes were exposed to insulin (50 mU/ml, 1 h) or left 
unstimulated (controls). Total and polysomal RNA were analysed using 
microarrays. The data were normalised to controls. Transcripts with differen-
tial expression in insulin-treated cells relative to controls were identified 
(>1.25-fold difference; * FDR < 0.05 insulin vs controls for polysomal RNA, # 
FDR < 0.05 insulin vs controls for total RNA, t-test with Benjamini and Hoch-
berg false discovery rate correction). Mean raw fluorescence values are pro-
vided for controls, with mean expression relative to controls for insulin-
treated cells (n = 4). For transcripts represented by more than one probeset, 
the probesets and corresponding raw values are listed. RNAs are listed 
according to translational regulation and in order of functional category 
then alphabetical order of the gene symbol. AS = Antisense.
Additional file 5 Regulation of polysomal and total RNA expression in 
cardiomyocytes in response to ET-1 (Microsoft Word Table). Neonatal 
rat cardiomyocytes were exposed to ET-1 (100 nM, 1 h) or left unstimulated 
(controls). Total and polysomal RNA were analysed using Affymetrix rat 
genome 230 2.0 microarrays. The data were normalised to controls. Transcripts 
with differential expression in ET-1-treated cells relative to controls were 
identified (>1.25-fold difference; * FDR < 0.05 ET-1 vs Controls for polysomal 
RNA, # FDR < 0.05 ET-1 vs Controls for total RNA, t-test with Benjamini and 
Hochberg false discovery rate correction). Mean raw fluorescence values 
are provided for controls, and mean expression relative to controls is pro-
vided for ET-1-treated cells (n = 4). For transcripts represented by more than 
one probeset, the probesets and mean corresponding raw values are listed. 
RNAs are listed according to translational regulation and in order of func-
tional category then alphabetical order of the gene symbol. AS = Antisense.
Additional file 6 Recruitment of TOP mRNAs to polysomes in cardio-
myocytes in response to insulin (Microsoft Excel Spreadsheet). Neonatal 
rat cardiomyocytes were exposed to insulin (50 mU/ml, 1 h) or left unstimu-
lated (controls). Total and polysomal RNA were analysed using microarrays. 
Probesets corresponding to ribosomal protein mRNAs and other established 
TOP mRNAs were identified. The mean raw values are provided for controls 
with the mean fold change (n = 4) induced by insulin relative to controls. *FDR 
< 0.05 for polysomal RNA from insulin-treated cells vs controls (t-test with Benja-
mini and Hochberg false discovery rate correction). Mouse and rat 5' UTR 
sequences up to and including the initiation codon are provided. Sequence 
identification used FANTOM3 and NCBI databases and the database of tran-
scriptional start sites (DBTSS). The TOP sequence is shown in red. [N.B. For some 
rat genes, a pseudogene was identified on the NCBI site; the correct gene was 
identified by comparison with the mouse genome on the basis of intron struc-
ture and location relative to adjacent genes (#). For other rat genes, the 5' UTR 
was short and the genomic sequence was used to identify regions of homol-
ogy with the mouse genome (†)].
Additional file 7 Recruitment of probable non-TOP mRNAs to poly-
somes in cardiomyocytes in response to insulin (Microsoft Excel 
Spreadsheet). Neonatal rat cardiomyocytes exposed to insulin (50 mU/ml, 
1 h) or left unstimulated (controls). Total and polysomal RNA were analysed 
using microarrays. Probesets corresponding to mRNAs with >1.25-fold 
increase in expression in polysomal RNA (but not total RNA) in response to 
insulin (FDR < 0.05, t-test with Benjamini -Hochberg false discovery rate cor-
rection) were identified. Mean raw fluorescence values are given for the 
controls with the mean fold change (n = 4) induced by insulin relative to 
controls. Mouse 5' UTR sequences up to and including the initiation codon 
are provided. Sequence identification used FANTOM3 and NCBI databases 
in addition to the database of transcriptional start sites (DBTSS). Presence 
(Y) or absence (N) of polypyrimidine or GC tracts, upstream open reading 
frames (uORFs), or 5' untranslated exons are indicated, in addition to GC 
content (%), UTR length and predicted minimum free energy (Mfe).
Additional file 8 Response of putative TOP mRNAs to insulin stimula-
tion in cardiomyocytes (Microsoft Excel Spreadsheet). Neonatal rat car-
diomyocytes were exposed to insulin (50 mU/ml, 1 h) or ET-1 (100 nM, 1 h) 
or left unstimulated (controls). Total and polysomal RNA prepared were 
analysed using Affymetrix rat genome 230 2.0 microarrays. Probesets corre-
sponding to TOP mRNAs identified by Yameshita et al. (Nuclei Acids Res. 
(2008) 36:3707-3715) were identified and the microarray data mined for the 
cardiomyocyte response. Results are the mean fold change (n = 4) in 
response to insulin or ET-1 relative to controls. Mean raw fluorescence val-
ues are given for the controls.
Additional file 9 Recruitment of probable non-TOP mRNAs to poly-
somes in cardiomyocytes in response to ET-1 (Microsoft Excel Spread-
sheet). Neonatal rat cardiomyocytes exposed to ET-1 (100 nM, 1 h) or left 
unstimulated (controls). Total and polysomal RNA were analysed using 
microarrays. Probesets corresponding to mRNAs with >1.25-fold increase in 
expression in polysomal RNA (but not total RNA) in response to ET-1 (FDR < 
0.05, t-test with Benjamini -Hochberg false discovery rate correction) were 
identified. Mean raw fluorescence values are given for the controls with the 
mean fold change (n = 4) induced by insulin relative to controls. Mouse 5' 
UTR sequences up to and including the initiation codon are provided. 
Sequence identification used FANTOM3 and NCBI databases in addition to 
the database of transcriptional start sites (DBTSS). Presence (Y) or absence 
(N) of polypyrimidine or GC tracts, upstream open reading frames (uORFs), 
or 5' untranslated exons are indicated, in addition to GC content (%), UTR 
length and predicted minimum free energy (Mfe).Markou et al. BMC Genomics 2010, 11:343
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